Carla R Gallasch
Carla is a National Industry PhD candidate working on developing and evaluating a cross-protective whole-inactivated vaccine against nontypable Haemophilus influenzae (NTHi). NTHi is a significant yet under-recognised human pathogen with growing prevalence in various invasive and non-invasive disease settings. Notably, it is now the leading bacterial pathogen causing middle ear infections in children and exacerbations of chronic obstructive pulmonary disease (COPD) in adults.
Abstracts this author is presenting: